Dicks Sporting Goods Inc vs DexCom, Inc. — how do they compare? Dicks Sporting Goods Inc trades at $136.65 (market cap $13.26B), while DexCom, Inc. trades at $84.11 (market cap $31.86B). The key difference: DexCom, Inc. is far larger — about 2.4× Dicks Sporting Goods Inc's market cap, and Dicks Sporting Goods Inc pays a 3.71% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dicks Sporting Goods Inc for 19 Days and DexCom, Inc. for 62 Days on average.
| DKS | DXCM | |
|---|---|---|
Market Cap | $13.26B | $31.86B |
Volume | 2,292,035 | 3,607,070 |
Sector | Consumer Cyclical | Health |
52-Week High | $239.17 | $92.34 |
52-Week Low | $121.15 | $54.84 |
Typical Hold Time | 19 Days | 62 Days |
Enterprise Value | $20.31B | $31.32B |
Dividend Yield | 3.71% | — |
Signals from Pluang's Aura AI — not financial advice
DICK'S Sporting Goods (DKS) trades at $134.63, up 2.63% today, with a bearish technical signal and mixed earnings history. The stock shows strong profitability with an 18.47% ROE and trades at a discount with a P/E of 14.86 and P/S of 0.57. Recent news highlights a securities class action lawsuit, while the company maintains a solid dividend and analyst consensus remains positive.
The outlook is cautious due to legal overhangs and a recent earnings miss, but the stock offers value with a consensus price target of $153.30. Upside potential exists if the company navigates litigation and maintains operational strength, though risks from competitive pressures and macroeconomic factors persist.
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth from $2.9B in 2022 to $4.66B in 2025. Profit margins have expanded significantly to 17.93%, while analyst sentiment remains overwhelmingly positive with 81% buy ratings. Recent news highlights the company's focus on Type 2 diabetes market expansion and leadership appointments.
DXCM presents a compelling growth story with expanding profitability and market opportunities, though elevated valuation multiples and technical bearish signals warrant caution. The consensus price target of $95.07 suggests 13% upside potential, but investors should monitor competitive pressures and reimbursement challenges in the CGM market.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →